(A patient with abnormal growth had asuppression studythat includedfive glucose testsandfive human growth hormone tests.

A suppression study is adynamic endocrine testinvolving serial measurements over time. CPT80430represents thesuppression function testitself (the study framework), while the individual lab analytes measured during the test are reported with their specific assay codes based on the test protocol. The scenario includesfive glucose testsandfive human growth hormone (HGH) testsperformed as part of the study. Glucose testing is reported with82947per test, and growth hormone testing is reported with83003per test. Because the stem specifiesfive of each, correct reporting includes80430plus82947 × 5and83003 × 5. Options that report only one unit of 82947/83003 (or reduce the number of tests) fail to reflect the documented serial testing frequency. CPC exam tip: when a dynamic study is described, do not stop at the function test code—also capture theserial analyte measurementswhen the question explicitly provides the number of lab draws/tests. Therefore, the correct coding is80430, 82947 × 5, 83003 × 5.